🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 8

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 8 of 20
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
May 2, 2024 at 11:12 PM#36
DataDave said:
Worth stating the units and the reference range whenever you post a number here.

That reframing is the part I needed. I will report back once I have actually tried it.

Last edited: May 3, 2024 at 1:12 AM
15 15fiona_VT, denise_HTX, raj_cambridge and 12 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
May 6, 2024 at 1:55 PM#37

Clinical perspective, offered as context rather than as advice. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Worth separating that from the trial evidence, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: May 6, 2024 at 7:55 PM
14 14TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 11 others
Reply Quote Save Share Report
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
May 10, 2024 at 4:36 AM#38
JenPlateau said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

This matches mine closely enough to be worth saying so out loud. Nothing to add that would improve it.

13 13james_edin, FranDenver, Dr.BariatricHTX and 10 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
May 13, 2024 at 7:14 PM#39
JenPlateau said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Adding the part of the answer the thread has not reached. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Worth separating that from the trial evidence, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

12 12Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 9 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
May 17, 2024 at 9:50 AM#40

The figures, for anyone assembling their own picture. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

40 15Dr.EndoEP, GraceAZ_72, carl_compliance and 37 others
Reply Quote Save Share Report
167891020

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register